Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-6 of  6 results for ""Antibodies, Monoclonal""

Your Filters

Publication : ebiomedicine Subject : covid-19 Subject : emotional engagement Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.

  • Authors : Wilhelm A; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.; Widera M

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Viral Vaccines*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/therapeutic use SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2022 Aug; Vol. 82, pp. 104158. Date of Electronic Publication: 2022 Jul 11.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.

  • Authors : Aggarwal A; The Kirby Institute, University of New South Wales, New South Wales, Australia.; Akerman A

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics; Angiotensin-Converting Enzyme 2/Angiotensin-Converting Enzyme 2/Angiotensin-Converting Enzyme 2/genetics SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2022 Oct; Vol. 84, pp. 104270. Date of Electronic Publication: 2022 Sep 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies.

  • Authors : Tada T; Department of Microbiology, NYU Grossman School of Medicine, 430 East 29th Street, Alexandria West Building, Rm 509, New York, NY 10016, USA.; Zhou H

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Monoclonal SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2022 Apr; Vol. 78, pp. 103944.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print Cited Medium: Internet ISSN: 2352-3964

Record details

Read More Add to Saved list
×
Academic Journal

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

  • Authors : Saunders N; Virus & Immunity Unit, Department of Virology, Institut Pasteur; CNRS UMR 3569, Paris, France

Subjects: COVID-19* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics; Antibodies, Monoclonal, Humanized SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2022 Mar; Vol. 77, pp. 103934. Date of Electronic Publication: 2022 Mar 13.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.

  • Authors : Gadani SP; Division of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Reyes-Mantilla M

Subjects: Immunity, Cellular* ; Immunity, Humoral*; COVID-19/COVID-19/COVID-19/*immunology

  • Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103636. Date of Electronic Publication: 2021 Oct 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

Subjects: Antibody Formation/Antibody Formation/Antibody Formation/*drug effects ; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*therapeutic use

  • Source: EBioMedicine [EBioMedicine] 2021 Oct; Vol. 72, pp. 103581. Date of Electronic Publication: 2021 Sep 22.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-6 of  6 results for ""Antibodies, Monoclonal""